A number of research firms have changed their ratings and price targets for GlaxoSmithKline plc (LON: GSK): 2/17/2017 – GlaxoSmithKline plc had its price target raised by analysts at Jefferies Group LLC from GBX 1,780 ($22.18) to GBX 1,800 ($22.43). They now have a “buy” rating on the stock. 2/16/2017 – GlaxoSmithKline plc had its […]